Book contents
- Frontmatter
- Contents
- Preface
- List of abbreviations
- 1 Drug targeting, drug discovery, and brain drug development
- 2 Invasive brain drug delivery
- 3 Lipid-mediated transport and carrier-mediated transport of small molecules
- 4 Receptor-mediated transcytosis of peptides
- 5 Vector discovery: genetically engineered Trojan horses for drug targeting
- 6 Linker strategies: the engineering of multifunctional drug formulations
- 7 Protein neurotherapeutics and peptide radiopharmaceuticals
- 8 Antisense neurotherapeutics and imaging gene expression in vivo
- 9 Gene therapy of the brain
- 10 Blood–brain barrier genomics
- References
- Index
- Plate section
References
Published online by Cambridge University Press: 08 January 2010
Book contents
- Frontmatter
- Contents
- Preface
- List of abbreviations
- 1 Drug targeting, drug discovery, and brain drug development
- 2 Invasive brain drug delivery
- 3 Lipid-mediated transport and carrier-mediated transport of small molecules
- 4 Receptor-mediated transcytosis of peptides
- 5 Vector discovery: genetically engineered Trojan horses for drug targeting
- 6 Linker strategies: the engineering of multifunctional drug formulations
- 7 Protein neurotherapeutics and peptide radiopharmaceuticals
- 8 Antisense neurotherapeutics and imaging gene expression in vivo
- 9 Gene therapy of the brain
- 10 Blood–brain barrier genomics
- References
- Index
- Plate section
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Brain Drug TargetingThe Future of Brain Drug Development, pp. 301 - 346Publisher: Cambridge University PressPrint publication year: 2001